8th Symposium
8thSymposiumMultidisciplinaryManagement ofNeuroendocrineTumoursÀras Na Mac Léinn,DeVere Hall, Student CentreUniversity College CorkFriday 2nd November 2018THIS CONFERENCEHAS BEENACCREDITED WITH6 CPDPOINTSTHROUGHTHE RCSI
SPEAKERSProfessor Kjell ÖbergSenior Professor, Department of Medical Sciences,Endocrine Tumorbiology, Akademiska sjukhuset, Uppsala, SwedenProfessor Reza KianmaneshProfessor in Digestive and Oncological Surgery,University Hospital Centre de ReimsDr Prakesh ManoharanConsultant Radiologist & Nuclear Medicine Physician,The Christie NHS Foundation Trust, ManchesterProfessor Martyn CaplinProfessor of Gastroenterology and GI & Tumour Neuroendocrinology,Royal Free Hospital, LondonProfessor Juan ValleProfessor and Honorary Consultant in Medical Oncology,The Christie NHS Foundation Trust, ManchesterProfessor Dr Marnix G E H LamProfessor of Nuclear Medicine, UMC Utrecht, NetherlandsProfessor Jean Yves ScoazecProfessor of Pathology, Université Paris SudProfessor Dermot O'TooleProfessor in Gastroenterology & Clinical Medicine,Trinity College Dublin / Consultant Gastroenterologist,St James's Hospital, DublinMr Ross CarterConsultant Pancreatic Surgeon, Glasgow Royal Infirmary, ScotlandProfessor Kevin ConlonProfessor of Surgery and Consultant HBP Surgeon,Trinity College Dublin and Tallaght and St Vincent’s Hospitals, DublinDr Martin BuckleyConsultant Gastroenterologist, Mercy University HospitalMr Criostóir O’SúilleabháinConsultant HBP and Upper GI Surgeon, Mercy University HospitalTHIS CONFERENCEHAS BEENACCREDITED WITH6 CPDPOINTSTHROUGHTHE RCSI
PROGRAMME08:45Registration08:45Welcome Address & IntroductionDr Derek Power, Consultant Medical Oncologist,Mercy University Hospital, CorkFriday 2ndNovemberSession One: Science of NETChairpersons:Dr Bill Bennett, Consultant Histopathologist,Cork University Hospital, CorkDr Stephen Skehan, Consultant Radiologist,St Vincent’s University Hospital, Dublin09:00Update on Pathology of Neuroendocrine TumoursProfessor Jean Yves Scoazec, Professor of Pathology,Université Paris Sud, France09:30Locoregional Treatments of Neuroendocrine TumoursProfessor Dr Marnix G.E.H. Lam,Professor of Nuclear Medicine, UMC Utrecht, Netherlands10:00Theranostic Update in Neuroendocrine TumoursDr Prakash Manoharan, Consultant Radiologist &Nuclear Medicine Physician, The Christie NHSFoundation Trust, Manchester, United Kingdom10:30Coffee Break8th Symposium Multidisciplinary Management of Neuroendocrine Tumours09:00–10:303
PROGRAMME continuedSession Two: Systemic Treatments of NETs11:00–12:30Chairpersons:Dr Greg Leonard, Consultant Medical Oncologist,Galway University Hospital, GalwayProfessor Liam Grogan, Consultant Medical Oncologist,Beaumont Hospital, Dublin11:00The role of Somatostatin Analogues and Biotherapy in NETsProfessor Martyn Caplin, Professor of Gastroenterologyand G.I. & Tumour Neuroendocrinology, Royal Free Hospital,London, United Kingdom11:30The role of Chemotherapy and Molecular Targeted Agentsin the Management of NETsProfessor Juan Valle, Professor and Honorary Consultantin Medical Oncology, The Christie NHS Foundation Trust,Wilmslow Road, Manchester, United Kingdom12:00Emerging developments in NETs: Therapeutic DevelopmentsProfessor Dermot O’Toole, Consultant in Gastroenterology& Clinical Medicine, Trinity College Dublin;Clinical Lead, National Centre for Neuroendocrine Tumours,St. Vincent’s University Hospital, Dublin12:30LunchSession Three: Surgical Treatment of NETs13:45–14:454Chairpersons:Mr Justin Geoghegan, Consultant HBP and Liver Transplant Surgeon,St Vincent’s University Hospital, DublinProfessor Kevin Conlon, Professor of Surgery and ConsultantHBP Surgeon, Trinity College Dublin, and AMNCH Tallaghtand St Vincent’s Hospitals, Dublin13:45Modern Surgical Management of MidgutNeuroendocrine TumoursProfesseur Reza Kianmanesh,Professor in Digestive and Oncological Surgery,Centre Hospitalier Universitaire de Reims, France14:15Surgery For Functioning and Non-Functioning PNETSMr Ross Carter, Consultant Pancreatic Surgeon,Glasgow Royal Infirmary, Scotland8th Symposium Multidisciplinary Management of Neuroendocrine Tumours
Session Four: NET for the General Surgeonand GastroenterologistChairpersons:Mr Gerry McEntee, Consultant HBP Surgeon,Mater Misercordiae University Hospital, DublinMr Adrian O’Sullivan, Consultant HBP Surgeon,Mercy and Cork University Hospitals, Cork14:4514:45–15:45‘What We Should Know about NETS.’1. Gastric NETsDr Martin Buckley, Consultant Gastroenterologist,Mercy University Hospital2. Colorectal NETsProfessor Dermot O’Toole, Consultant inGastroenterology& Clinical Medicine,Trinity College Dublin; Clinical Lead,National Centre for Neuroendocrine Tumours,St Vincent’s University Hospital, Dublin3. PhaeochromocytomasProfessor Kevin Conlon, Professor of Surgery andConsultant HBP Surgeon, Trinity College Dublinand Tallaght and St Vincent’s Hospitals, Dublin4. Appendicular NETsMr Criostóir O’Súilleabháin, Consultant HBPand Upper GI Surgeon, Mercy University Hospital15:45Coffee BreakSession Five: Case PresentationsChairperson:Mr Criostóir O’Súilleabháin, Consultant HBP and Upper GI Surgeon,Mercy University Hospital16:15Professor Justin GeogheganConsultant HBP and Liver Transplant Surgeon,St Vincent’s University Hospital, DublinMr Emir HotiConsultant HBP and Liver Transplant Surgeon,St Vincent’s University Hospital, DublinDr Derek PowerConsultant Medical Oncologist,Mercy University Hospital, Cork8th Symposium Multidisciplinary Management of Neuroendocrine Tumours16:15–17:155
PROGRAMME continuedSession Six: Professor Gerry O’SullivanMemorial Lecture17:15–18:00IntroductionMr Tommie Gorman, Journalist and RTE Northern Ireland Correspondent17:15Professor Gerry O’Sullivan Memorial LectureNeuroendocrine Tumours, from the past to the presentProfessor Kjell Öberg, Senior Professor,Department of Medical Sciences,Endocrine Tumorbiology, Akademiska sjukhuset,Uppsala, Sweden618:00Meeting Ends19:30Conference DinnerLewis Glucksman Gallery, University College Cork8th Symposium Multidisciplinary Management of Neuroendocrine Tumours
SPEAKER BIOGRAPHIESProfessor Jean-Yves ScoazecProfessor of Pathology, Université Paris SudJean-Yves Scoazec, MD, PhD, is currently head of theDepartment of Pathology and Laboratory Medicine in GustaveRoussy Cancer Campus in Villejuif, France and director of theresearch group “Molecular Analysis, Imaging and Modelling ofCancer” Unit in the same institution. Since 2011, he coordinatesthe French expert network for the pathological diagnosis ofneuroendocrine tumors (TENPath), which is supported by theFrench National Cancer Institute (INCa). He has been a memberof the ENETS Advisory Board. Professor Scoazec has authoredmore than 450 original articles and has contributed to the recentWHO classifications of gastro-entero-pancreatic neuroendocrinetumors (2010 and 2017). His main research interests arethe cellular and molecular mechanisms of neuroendocrinetumor initiation and progression and the mechanisms ofneuroendocrine differentation in carcinomas.09:00–09:30Professor Dr Marnix G.E.H. LamProfessor of Nuclear Medicine, Chief of Nuclear Medicine,University Medical Center Utrecht, department ofRadiology and Nuclear Medicine, The Netherlands.Marnix Lam is trained as a Nuclear Medicine Physician andRadiologist. He is a staff member of the department of Radiologyand Nuclear Medicine in the UMC Utrecht since 2007. Duringhis ‘Dutch Cancer Society (KWF)’ research fellowship ontranslational and clinical research (2010 – 2014), he completeda 2-year research fellowship at Stanford University. In 2013he was appointed chief of Nuclear Medicine, and in 2016 hewas appointed professor of Nuclear Medicine. Translationalresearch in molecular medicine has been the scope of hisscientific work, with a focus on oncology. The aim is to bring newradiopharmaceuticals to clinical practice. This specifically resultedin the introduction of new oncological treatment modalities inthe Netherlands, such as bone seeking radiopharmaceuticals forthe palliation of metastatic bone pain (153Sm-EDTMP, 188ReHEDP, 223Ra-chloride), protein-receptor radionuclide therapy(177Lu-PSMA, 177Lu-HA-dotatate), and radioembolization fortreatment of hepatic malignancies (90Y microspheres and166Ho microspheres). Current research is focussed on dosimetryof therapeutic radiopharmaceuticals, image-guided treatmenttechnology, alfa- and beta-emitting isotopes for therapeuticpurposes, intra-arterial and intra-tumor treatment approaches,and radio-immunotherapy.8th Symposium Multidisciplinary Management of Neuroendocrine Tumours09:30–10:007
SPEAKER BIOGRAPHIES continuedDr Prakash ManoharanConsultant Radiologist & Nuclear Medicine Physician,The Christie NHS Foundation Trust,Manchester, United Kingdom10:00–10:30Dr Prakash Manoharan trained in medicine at the University ofBristol. He then undertook post graduate training in generalmedicine (MRCP) and radiology (FRCR). He is dually accreditedin radiology and nuclear medicine with specialist cross sectionaltraining in The Leeds Teaching Hospitals (CT, MRI,onco-radiologyand nuclear medicine). After completing his USMLE, he undertookfurther accredited specialist training in The University of MichiganHealth System, Ann Arbor, USA in molecular imaging, nuclearmedicine and radionuclide targeted therapies. His sub specialisedinterest is in onco-radiology, neuroendocrine tumours and HPBoncology. He is a Consultant Radiologist and Nuclear MedicinePhysician at The Christie, a role which commenced in January2007. He is the deputy clinical lead of the ENETS centre ofexcellence at The Christie and the MRT lead for NET. In April 2016,he was appointed Academy Director at The Christie. This roleincludes providing clinical leadership in delivering PET CT serviceto 70% of the contracted work load of England. His researchinterest includes molecular and functional imaging looking atearly biomarkers of response.Professor Martyn CaplinProfessor of Gastroenterologyand G.I. & Tumour Neuroendocrinology,Royal Free Hospital, London, United Kingdom11:00–11:308Martyn Caplin is Professor of Gastroenterology & GINeuroendocrinology at the Royal Free Hospital and UniversityCollege London. He leads The Royal Free Hospital’s “EuropeanNeuroendocrine Tumour Society’s Centre of Excellence”.Furthermore, he leads scientific and clinical research programmesinto neuroendocrine tumours. In addition to being the ChairmanENETS (2014-2016), he now serves on its advisory board. He hasbeen with ENETS since its foundation in 2004. He received aLifetime Achievement Award from the UK & Ireland NeuroendocrineTumour Society (UKI NETS) in recognition of his clinical leadershipand research in the field of NETs. He is a founder and Past-Chairmanof the UK & Ireland Neuroendocrine Tumour Society. 2006-2014 hewas a member of the National Cancer Research Institute (NCRI)Upper-G.I. Cancer Committee and he is a Past-Chairman of theNCRI Neuroendocrine Tumour group. He is a Patron of the NETPatient Foundation. He has published over 200 peer review papers,written multiple book chapters and co-authored two books. Heregularly lectures both nationally and internationally. 2006-2012he was the clinical lead for “NHS Evidence” for Gastroenterologyand Liver diseases (under the auspices of NICE), chairing annualevidence updates into gastrointestinal and liver disorders.8th Symposium Multidisciplinary Management of Neuroendocrine Tumours
Professor Juan W. ValleProfessor and Honorary Consultant in Medical Oncology,The Christie NHS Foundation Trust, Wilmslow Road,Manchester, United KingdomJuan Valle is a Professor of Medical Oncology in the Universityof Manchester (Division of Cancer Sciences, Faculty of Biology,Medicine and Health); part of the Manchester Academic HealthSciences Centre (MAHSC). He is based at The Christie NHSFoundation Trust within the Gastrointestinal Disease Groupand treats cancers of the pancreas, liver and biliary tract, andneuroendocrine tumours (NETs). He is the lead for The ChristieNeuroendocrine European Neuroendocrine Tumour Society(ENETS) Centre of Excellence.Professor Valle is a member of the following subgroups of theNational Cancer Research Institute (NCRI) Upper GI ClinicalStudies Group: hepatobiliary, pancreatic and neuroendocrine(which he Chaired between 2013 – 2017). He is Secretary of theUK and Ireland NET Society (UKINETS); member of the EORTCHepatobiliary Task Force; EORTC Gastrointestinal Tract CancerGroup; the National Cancer Institute Hepatobiliary Task Force[USA]; and Vice-Chair of the Cholangiocarcinoma FoundationMedical Advisory Board [USA].11:30–12:00He has been awarded a number of grants for research leadingto numerous publications and presentations and national andinternational meetings and is a peer-reviewer for a number ofinternational medical journals.He is a member of ASCO (American Society of ClinicalOncology), ESMO (European Society of Medical Oncology), UKINETS (UK and Ireland Neuroendocrine Tumour Society) andENETS (European Neuroendocrine Tumour Society).Professor Dermot O’TooleConsultant in Gastroenterology& Clinical Medicine,Trinity College Dublin; Clinical Lead,National Centre for Neuroendocrine Tumours,St Vincent’s University Hospital, DublinDermot O’Toole is Professor in Gastroenterology andClinical Medicine at Trinity College Dublin and ConsultantGastroenterologist in St James’s Hospital and St Vincent’sUniversity Hospital Dublin. He graduated from TCD and haspostgraduate degrees from TCD, Universities of Paris and Angers.He has served on the executive committee of the EuropeanNeuroendocrine Tumours Society (ENETS) and is current Presidentof ENETS helping to develop guideline papers and standards ofcare initiatives in the field of NET. He served as Chair of the ENETSdriven European Centre of Excellence program from 2008-18. Hehas been involved in many national and international researchactivities in GI oncology and is a member of several professionalbodies in Europe and North America serving as advisor on nationalhealth care projects/initiatives and on patient advocacy groups.8th Symposium Multidisciplinary Management of Neuroendocrine Tumours12:00–12:309
SPEAKER BIOGRAPHIES continuedProfessor Reza KianmaneshProfessor in Digestive and Oncological Surgery,Centre Hospitalier Universitaire de Reims, France13:45–14:15Reza Kianmanesh, MD, PhD is an oncological surgeonpredominantly specialized on the management of liver, pancreas,colorectal (peritoneal carcinomatosis) and neuroendocrinedigestive malignancies. He is the chief of the department ofdigestive and endocrine surgery at Robert Debré UniversityHospital in Reims, France since 2011. He obtained his MD, PhDand full professor promotions in Paris (Bichat-Beaujon-Paris 7Dierot University). Since 2012, he works in collaboration withPr G. Cadiot and Pr O. Bouché (hepato-gastro-enterologists &digestive oncologists) in Reims HU and participates actively tothe management of neuroendocrine and digestive malignancies.Mr Ross CarterConsultant Pancreatic Surgeon,Glasgow Royal Infirmary, Scotland14:15–14:4510Ross Carter was born and schooled in Northern Ireland beforegraduating from the University of Glasgow in 1983. He wasappointed to Glasgow Royal Infirmary in 1996 as Consultantpancreatico-biliary endoscopist and surgeon. He has developeda particular interest in the surgical, laparoscopic and endoscopicmanagement of pancreatic disease, particularly the minimallyinvasive management of the complications arising from severeacute pancreatitis. He is a past President of the PancreaticSociety of Great Britain and Ireland, and the Honorary Secretaryof both the British Society of Gastroenterology PancreaticSection and the PSGB&I.He has been involved in the creation of UK and Internationalguidelines for the management of pancreatic disease. He is on anumber of steering groups for National and international clinicalstudies in pancreatology. His research interests include clinicaland translational pancreatic cancer, and acute pancreatitis. Hehas authored and co authored over 100 peer reviewed articlesand 20 book chapters. He currently sits on the editorial boardof HpB and reviews research and clinical papers for numerousinternational journals. He was involved with the developmentof the Scottish National HpB network and has an interest in theimprovement of hospital services for patients with pancreatic andhepatobiliary disease.8th Symposium Multidisciplinary Management of Neuroendocrine Tumours
Dr Martin BuckleyConsultant Gastroenterologist,Mercy University HospitalDr Martin Buckley studied medicine at University College Corkand qualified in 1989. After an internship at the Mercy Hospital,he did his general medical training at the Federated VoluntaryHospitals Dublin. He trained in Gastroenterology in the Dublinteaching hospitals and was Lecturer in Medicine at Trinity CollegeDublin for two years before completing a therapeutic endoscopyfellowship at CHU L’Archet, Nice, France. He was appointedconsultant gastroenterologist at Tallaght Hospital, Dublinin 1998. He moved to his current position at the Mercy UniversityHospital in Cork in 2003 where he works as a therapeuticendoscopist with a special interest in ERCP/EUS/Early epithelialneoplasia. He has contributed to over 100 peer-reviewed papersand 30 textbooks.14:45–15:00Professor Kevin ConlonProfessor of Surgery and Consultant HBP Surgeon,Trinity College Dublin and Tallaght andSt Vincent’s Hospitals, DublinProfessor Kevin Conlon is Professor of Surgery at Trinity CollegeDublin, and an HPB surgeon at St. Vincent’s University Hospital,Dublin, Ireland. He is a surgical oncologist with a clinical interestin benign and malignant diseases of the upper gastrointestinaltract. He is currently the Editor-in-Chief of Digestive Surgeryand is on the editorial board of eight international journals. Heis a member of many cooperative groups. He is a Past-President(2011) of the Pancreatic Society of Great Britain & Ireland (PSGBI).He is President-Elect of the on (E-AHPBA) and Secretary General of theInternational Hepato-Pancreato-Biliary-Association (IHPBA). Heis a member of the Council of the Royal College of Surgeons inIreland and of the Association of Surgeons of Great Britain andIreland. He is also a member of the European Surgical Associationand the International Surgical Group.8th Symposium Multidisciplinary Management of Neuroendocrine Tumours15:15–15:3011
SPEAKER BIOGRAPHIES continuedMr Criostóir Brian Ó SúilleabháinConsultant HBP and Upper GI Surgeon,Mercy University HospitalBorn in Kiel, Germany in 1965, Criostoir, grew up in Cork andgraduated from The Medical School, University College Cork, in1990. He was appointed Research Fellow to Dr John A Mannick,Moseley Distinguished Professor of Surgery, Harvard MedicalSchool, at the Brigham and Women’s Hospital, Boston in 1994.This led to an M.D. thesis awarded from the National University ofIreland in 1998.15:30–15:45Much of his higher surgical training was in the West of Scotland,where he worked under and was greatly influenced by ProfessorClem Imrie, at the Glasgow Royal Infirmary. It was here that hisinterest in Pancreatic Diseases, both benign and malignant, wasessentially nurtured.In 2001, he was appointed Honorary Clinical Associate toProfessor Sheung-Tat Fan, at the Hepato-Biliary Pancreatic/Transplant Unit, Queen Mary Hospital, University of HongKong Medical Centre. He returned to Edinburgh in 2002, tobecome Clinical Fellow to Professor O. James Garden until hewas appointed Consultant Hepatobiliary Pancreatic and Liver/Pancreas Transplant Surgeon at the Freeman Hospital NewcastleUpon-Tyne, UK, in June 2003. In September 2006, he acceptedthe Upper GI/HBP Consultant position in the Mercy UniversityHospital Cork. Together with Professor Gerry O’Sullivan, he hasestablished the Upper Gastrointestinal Cancer Centre.His main areas of interest are in the management of PancreaticMalignancy, resectional surgery for Colorectal Liver Metastases,and the treatment of Neuroendocrine and GastrointestinalStromal tumours.128th Symposium Multidisciplinary Management of Neuroendocrine Tumours
Dr Kjell ÖbergSenior Professor, Department of Medical Sciences,Endocrine Tumorbiology, Akademiska sjukhuset,Uppsala, SwedenDr Kjell Öberg is Professor of Endocrine Oncology at the MedicalFaculty of Uppsala University. He was the former head of theDepartment of Endocrine Oncology, University Hospital, and he isa specialist in endocrinology and internal medicine. He founded theDept. of Endocrine Oncology at Uppsala University Hospital and has40 year’s experience in the field of neuroendocrine tumors. Between1986 and 1992 he was clinical associate director of the LudwigInstitute for Cancer Research. From 1998 to 2002 he was chairmanof the Department of Medical Sciences at the Medical Faculty ofUppsala University. July 2002 until June 2008 he was the Dean of theMedical Faculty. He was the chairman for the Centre of Excellenceof Endocrine Tumors and Vice chairman of the Department ofEndocrine Oncology, University Hospital, Uppsala until May 2013, atpresent time he is senior advisor at the same department. Currently,Adjunct Professor of Surgery at Vanderbilt University, Nashville, US.17:15–18:00Dr. Öberg was one of the founders and coordinator of the EuropeanNeuroendocrine Tumor Network (ENET) 1995-2000 and was pastchairman of the Nordic Neuroendocrine Tumor Group. He haspioneered the treatment of carcinoid tumor patients with interferonand somatostatin analogues and developed assays for tumormarkers such as Chromogranin A and radiological proceduresincluding specialized PET scans.In 1988 he was the first to describe a genetic deletion in multipleendocrine neoplasia Type 1 (MEN1). Dr Öberg has given many hundredsof presentations at international meetings and published more than500 papers within his research field, H-factor 67 and 14,850 citations.In addition he is the author of numerous chapters on Carcinoid tumorsin several international textbooks including William’s Textbook ofEndocrinology, Leslie de Groot’s Textbook of Endocrinology, ClinicalEndocrinology and Fordtran’s Textbook of Gastroenterology. Dr. Öbergis Editor-in Chief of World Journal of Gastroenterolgy (WJG).In 1991 Dr. Öberg received the European Interferon Research reward.In 2003 he received the award “Eminent Scientist Year 2003” bythe International Research Promotion Council (IRPC) and WorldScientist Forum and in 2004 he was awarded the European GoldMedal in Endocrinology from the English Endocrine Society. InNovember 2006 he received the Harry Boström Award Lecture atSwedish Medical Society, the University Hospital Clinical ResearchAward in 2011. In 2014 he received the Rudbeck Medallion forexcellence in research and the Life Time Achievement Award fromNorth American Neuroendocrine Society. January 2017 Dr Öbergwas awarded with The Swedish Endocrine Society Gold Medal forprominent research and clinical activities and in March 2017 hereceived Lifetime Achievement Award by European NeuroendocrineTumor Society (ENETS). In October of 2017, Lifetime Achievementfrom Asian Pacific Neuroendocrine Tumor Society (AP-NETS).Dr. Öberg is a member of the Royal Society of Sciences, member ofSwedish Society of Medical Research, Honorary member of FinnishOncology Society, Finnish Endocrine Society and Honorary memberof Spanish Neuroendocrine NET-work. Dr. Öberg is Vice President ofENETS since March 2012 and also a member of NANETS AdvisoryBoard as well as several other national and international research andscientific boards and many scientific journal review boards.8th Symposium Multidisciplinary Management of Neuroendocrine Tumours13
NOTES148th Symposium Multidisciplinary Management of Neuroendocrine Tumours
NOTES8th Symposium Multidisciplinary Management of Neuroendocrine Tumours15
Organising CommitteeMr Criostóir O’Súilleabháin, Consultant Surgeon, Mercy University HospitalDr Derek Power, Consultant Medical Oncologist, Mercy University HospitalDr Brian Bird, Consultant Medical Oncologist, Bon Secours HospitalPLATINUM SPONSORSGOLD SPONSORSILVER SPONSOR
11:00 The role of Somatostatin Analogues and Biotherapy in NETs Professor Martyn Caplin, Professor of Gastroenterology and G.I. & Tumour Neuroendocrinology, Royal Free Hospital, London, United Kingdom 11:30 The role of Chemotherapy and Molecular Targeted Agents in the Management of NETs
Essays on Modern Japanese Thought. 4,2 Symposium: Japan in the 1970's. 5,2 Symposium: Translation and Japanese Studies. Introduction by Roy Andrew Miller. 6,1 Symposium on Japanese Society. Introduction by Susan B. Hanley. 8,1 Symposium on Ie Society. Introduction by Kozo Yamamura. 11,1 Symposium: Transition From Medieval to Early Modern Japan.
End of the Year Celebrations June 3rd: 8th Grade Breakfast (OLA Gym; 8:30 AM); Grades 1-4 Field Trip to the Bronx Zoo June 4th: 8th Grade Dinner-Dance (7 PM) June 5th: Altar Server/SCOLA Trip June 6th: 8th Grade Trip to Philadelphia June 7th: 8th Grade Honors (Morning Announcements, 8:05 AM); Graduation Mass (OLA Church 8:30 AM) June 8th: 8th Grade Graduation (OLA Church, 1 PM)
produce this symposium. We hope that this year's symposium will enable all attendees to reach new heights in applying the perspectives and science of human factors/ergonomics to the future of health care. Joseph R. Keebler, PhD Anthony D. (Tony) Andre, Symposium Chair PhD, CPE Symposium Cochair :HOFRPH 1
8th Grade Summer Math Packet Dear Future 8th Grader, This summer math packet is designed to help you keep your math skills strong before returning to 8th grade in the fall. We want you to feel confident on the following skills and problems when you begin 8th grade. If you get to a problem you are confused on, here are some ideas to help:
Watch for announcements about the Innov8te NRP: Introduction to the Neonatal Resuscitation Program, 8th Edition webinar on February 18, 2021 that will answer all your questions about NRP 8th Edition and RQI for NRP. NRP 8th EDITION MATERIALS – WHAT’S NEW The Textbook of Neonatal Resuscitation, 8th edition, will be available on June 1, 2021.
NMPED 8th Grade Science EOC Blueprint Project Management by 2 Purpose Statement 8th Grade Science The 8th Grade Science End-of-Course (EOC) exam is intended to measure student proficiency of the New Mexico Science Standards. This course-level exam is provided to all students who have completed 8th Grade Science or related courses. This exam can be given for the following STARS course codes:
Vienna Motor Symposium 2021 42nd International Vienna Motor Symposium 29 - 30 April 2021 VIRTUAL PROGRAMME
Symposium Schedule Wednesday, February 19 0800-0840 Welcome Coffee, Collection of Badges and Delegate Packs 0840-0845 Seating and Safety Announcement 0845-0930 Symposium Opening Ceremony Keynote Speaker: His Excellency Salim Al Aufi Ministry of Oil and Gas, Oman Welcome Address: Shauna Noonan Occidental Petroleum Symposium Chair: Atika Al .
